Jinmin Miao

Jinmin Miao

Purdue University

H-index: 12

North America-United States

About Jinmin Miao

Jinmin Miao, With an exceptional h-index of 12 and a recent h-index of 12 (since 2020), a distinguished researcher at Purdue University, specializes in the field of Organic Chemistry, Medicinal Chemistry.

His recent articles reflect a diverse array of research interests and contributions to the field:

Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation

Inhibition of PRL2 Upregulates PTEN and Attenuates Tumor Growth in Tp53-deficient Sarcoma and Lymphoma Mouse Models

PRL2 phosphatase promotes oncogenic KIT signaling in leukemia cells through modulating CBL phosphorylation

Discovery of a SHP2 Degrader with In Vivo Anti-Tumor Activity

Small Molecule Degraders of Protein Tyrosine Phosphatase 1B and T‐Cell Protein Tyrosine Phosphatase for Cancer Immunotherapy

PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371

Driving axon regeneration by orchestrating neuronal and non-neuronal innate immune responses via the IFNγ-cGAS-STING axis

Discovery of a selective TC-PTP degrader for cancer immunotherapy

Jinmin Miao Information

University

Position

___

Citations(all)

879

Citations(since 2020)

493

Cited By

563

hIndex(all)

12

hIndex(since 2020)

12

i10Index(all)

13

i10Index(since 2020)

12

Email

University Profile Page

Google Scholar

Jinmin Miao Skills & Research Interests

Organic Chemistry

Medicinal Chemistry

Top articles of Jinmin Miao

Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation

2024/4/2

Jinmin Miao
Jinmin Miao

H-Index: 9

Inhibition of PRL2 Upregulates PTEN and Attenuates Tumor Growth in Tp53-deficient Sarcoma and Lymphoma Mouse Models

Cancer Research Communications

2024/1/2

PRL2 phosphatase promotes oncogenic KIT signaling in leukemia cells through modulating CBL phosphorylation

Molecular Cancer Research

2024/1/2

Discovery of a SHP2 Degrader with In Vivo Anti-Tumor Activity

Molecules

2023/10

Small Molecule Degraders of Protein Tyrosine Phosphatase 1B and T‐Cell Protein Tyrosine Phosphatase for Cancer Immunotherapy

Angewandte Chemie International Edition

2023/5/22

PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371

Blood

2023/1/19

Driving axon regeneration by orchestrating neuronal and non-neuronal innate immune responses via the IFNγ-cGAS-STING axis

Neuron

2023/1/18

Discovery of a selective TC-PTP degrader for cancer immunotherapy

Chemical Science

2023/10/24

A target enablement package for the inhibition of SHIP1 as a therapeutic strategy for the treatment of Alzheimer’s disease

Alzheimer's & Dementia

2022/12

Tumor cell–autonomous SHP2 contributes to immune suppression in metastatic breast cancer

Cancer Research Communications

2022/10/3

The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors

Nature communications

2021/11/1

SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer

Oncogene

2020/12/3

See List of Professors in Jinmin Miao University(Purdue University)